Loading provider…
Loading provider…
Hematology & Oncology Physician in Beverly Hills, CA
NPI: 1740505007Primary Employer
Cedars-Sinai Medical Care Foundation
cedars-sinai.org
HQ Phone
Get M.D. Navid's Phone Numberphone_androidMobile
Get M.D. Navid's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2023 - 2027
CT State Medical License
2016 - 2023
CT State Medical License
CA State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Yale-New Haven Medical Center
Fellowship • Hematology and Medical Oncology
2013 - 2016
Residency • Internal Medicine
2010 - 2013
University of Wisconsin–Madison
med.wisc.edu
Medical School
Until 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 85 | 141 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 52 | 62 |
| 3 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 45 | 64 |
| 4 | 80053Blood test, comprehensive group of blood chemicals | 41 | 59 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 34 | 43 |
Authors: Luis Raez, Brant Mittler, Suresh Ramalingam, Elaine Shum, Matthew Hellmann, Fang Wang, Mateusz Opyrchal, Emmett Schmidt
Journal: Clin Cancer Res
Publication Date: 2020-11-17
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Bone Marrow Biopsy, PROCEDURE: Biospecimen Collection, DRUG: Olaparib, PROCEDURE: Computed Tomography, DRUG: Ceralasertib, PROCEDURE: Bone Marrow Aspiration, PROCEDURE: Biopsy Procedure
Lead Sponsor: Takeda
Intervention / Treatment: DRUG: Pembrolizumab, DRUG: Modakafusp Alfa
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, PROCEDURE: Biospecimen Collection